Literature DB >> 27100794

Thrombopoietin Measurement as a Key Component in the Evaluation of Pediatric Thrombocytosis.

Nya D Nelson1, Andrea Marcogliese2,3, Katie Bergstrom3, Michael Scheurer3, Donald Mahoney3, Alison A Bertuch3,4.   

Abstract

JAK2, MPL, and CALR mutations, which underlie essential thrombocythemia (ET) in most adults, are infrequent in children. Consequently, additional tests are needed to confirm pediatric ET diagnoses. We report a child with suspected ET and normal JAK2, MPL, and CALR analyses. Serum thrombopoietin (TPO) was markedly elevated, leading to analysis of the TPO gene, TPHO, which contains an upstream open reading frame (uORF) known to repress THPO translation. Sequencing revealed a de novo, germline stopgain mutation in the uORF, explaining the elevated TPO and thrombocytosis. This finding suggests that screening TPO levels and, if elevated, THPO 5' UTR sequencing could be diagnostic.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  THPO; essential thrombocythemia; thrombocytosis; thrombopoietin; upstream open reading frame

Mesh:

Substances:

Year:  2016        PMID: 27100794      PMCID: PMC4916014          DOI: 10.1002/pbc.26032

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  18 in total

1.  Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.

Authors:  Ayalew Tefferi; Emnet A Wassie; Paola Guglielmelli; Naseema Gangat; Alem A Belachew; Terra L Lasho; Christy Finke; Rhett P Ketterling; Curtis A Hanson; Animesh Pardanani; Alexandra P Wolanskyj; Margherita Maffioli; Rosario Casalone; Annalisa Pacilli; Alessandro M Vannucchi; Francesco Passamonti
Journal:  Am J Hematol       Date:  2014-05-16       Impact factor: 10.047

Review 2.  Molecular diagnostics of myeloproliferative neoplasms.

Authors:  Stephen E Langabeer; Hajnalka Andrikovics; Julia Asp; Beatriz Bellosillo; Serge Carillo; Karl Haslam; Lasse Kjaer; Eric Lippert; Olivier Mansier; Elisabeth Oppliger Leibundgut; Melanie J Percy; Naomi Porret; Lars Palmqvist; Jiri Schwarz; Mary F McMullin; Susanne Schnittger; Niels Pallisgaard; Sylvie Hermouet
Journal:  Eur J Haematol       Date:  2015-05-18       Impact factor: 2.997

Review 3.  How we diagnose and treat essential thrombocythaemia.

Authors:  Samah Alimam; Bridget S Wilkins; Claire N Harrison
Journal:  Br J Haematol       Date:  2015-09-10       Impact factor: 6.998

4.  Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene.

Authors:  N Ghilardi; A Wiestner; M Kikuchi; A Ohsaka; R C Skoda
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

5.  Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia.

Authors:  L Pitcher; K Taylor; J Nichol; D Selsi; R Rodwell; J Marty; D Taylor; S Wright; D Moore; C Kelly; A Rentoul
Journal:  Br J Haematol       Date:  1997-12       Impact factor: 6.998

6.  Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort.

Authors:  Maria L Randi; Giulia Geranio; Irene Bertozzi; Concetta Micalizzi; Ugo Ramenghi; Fabio Tucci; Lucia D Notarangelo; Saverio Ladogana; Giuseppe Menna; Paola Giordano; Caterina Consarino; Piero Farruggia; Giulio A Zanazzo; Giovanni M Fiori; Roberta Burnelli; Giovanna Russo; Momcilo Jankovich; Edoardo Peroni; Elena Duner; Giuseppe Basso; Fabrizio Fabris; Maria C Putti
Journal:  Br J Haematol       Date:  2015-02-25       Impact factor: 6.998

7.  Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis.

Authors:  M Hou; J Carneskog; U H Mellqvist; D Stockelberg; M Hedberg; H Wadenvik; J Kutti
Journal:  Eur J Haematol       Date:  1998-08       Impact factor: 2.997

8.  Circulating thrombopoietin in clonal versus reactive thrombocytosis.

Authors:  Sema Karakuş; Osman I Ozcebe; Ibrahim C Haznedaroğlu; Hakan Göker; Düzgün Ozatli; Ali Koşar; Yahya BüyükaşIk; Derun Ertuğrul; Nilgün SayInalp; Serafettin KirazlI; Semra V Dündar
Journal:  Hematology       Date:  2002-02       Impact factor: 2.269

9.  Thrombopoietin production is inhibited by a translational mechanism.

Authors:  N Ghilardi; A Wiestner; R C Skoda
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

10.  Familial essential thrombocythemia associated with one-base deletion in the 5'-untranslated region of the thrombopoietin gene.

Authors:  T Kondo; M Okabe; M Sanada; M Kurosawa; S Suzuki; M Kobayashi; M Hosokawa; M Asaka
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

View more
  3 in total

1.  Chasing down the triple-negative myeloproliferative neoplasms: Implications for molecular diagnostics.

Authors:  Stephen E Langabeer
Journal:  JAKSTAT       Date:  2016-11-14

Review 2.  Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.

Authors:  Clemens Stockklausner; C M Duffert; H Cario; R Knöfler; W Streif; A E Kulozik
Journal:  Ann Hematol       Date:  2021-03-12       Impact factor: 3.673

3.  Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease.

Authors:  Marianne E M Yee; Glaivy Batsuli; Satheesh Chonat; Sunita Park
Journal:  Clin Case Rep       Date:  2020-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.